Real-time enrollment status for this metastatic pancreatic neuroendocrine tumor clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:48 AM UTC
| NCT Number | NCT05687123 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Neuroendocrine Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 9 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 13, 2026: Clinical trial NCT05687123 is currently recruiting participants. This clinical trial study for metastatic pancreatic neuroendocrine tumor is actively seeking new participants at 9 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05687123 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05687123 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.